ARTELO BIOSCIENCES, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ARTELO BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $174.00K, a 83.90% decline year-over-year.
- ARTELO BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $10.03M.
- ARTELO BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $3.31M.
- ARTELO BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $1.08M.
- ARTELO BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2021 was $8.10M, a 309.66% increase from fiscal 2020.
- ARTELO BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2020 was $1.98M, a 99.98% decline from fiscal 2019.
- ARTELO BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2019 was $8.38B, a 603989.17% increase from fiscal 2018.
- ARTELO BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2018 was $1.39M, a 64095.05% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $174.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $10.03M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $6.15M 8-K · filed 2026-03-17 | |
| 2025-09-30 | $3.31M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.08M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-08-13 | |
| 2024-12-31 | $112.00K 8-K · filed 2026-03-17 | |
| 2024-03-31 | $55.00K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $32.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-07-11 | $567.00K 8-K · filed 2025-07-11 |
| 2023-09-30 | $535.00K 10-Q · filed 2024-11-12 | |
| 2021-11-30 | $18.26M 10-Q · filed 2022-01-12 | |
| 2021-08-31 | $8.10M 10-K · filed 2023-03-31 | |
| 2021-06-30 | $1.20M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $6.02M 10-Q · filed 2022-05-12 | |
| 2020-11-30 | $6.58M 10-Q · filed 2022-01-12 | |
| 2020-08-31 | $1.98M 10-KT · filed 2022-03-21 | |
| 2020-05-31 | $380.68K 10-Q · filed 2021-07-12 | |
| 2019-08-31 | $8.38B 10-K · filed 2021-11-29 | |
| 2019-05-31 | $417.73K 10-Q · filed 2020-07-13 | |
| 2019-02-28 | $1.09M 10-Q · filed 2020-07-13 | |
| 2018-11-30 | $170.77K 10-Q · filed 2020-07-13 | |
| 2018-08-31 | $1.39M 10-K/A · filed 2019-12-18 | |
| 2018-05-31 | $268.65K 10-Q · filed 2019-07-15 | |
| 2018-02-28 | $582.14K 10-Q · filed 2019-07-15 | |
| 2017-11-30 | $10.00K 10-Q · filed 2019-07-15 | |
| 2017-08-31 | $2.16K 10-K · filed 2018-11-29 | |
| 2015-08-31 | $7.30K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | $15.80K 10-K · filed 2016-11-29 |
| 2014-08-31 | $30.00K 10-K · filed 2015-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |